Lantus SoloStar Insulin Pen from Japan
Lantus SoloStar is a long-acting insulin glargine injection for basal glycemic control in type 1 and type 2 diabetes. Each pre-filled pen delivers 3mL of 100 units/mL insulin in measured doses for patient self-administration. Falls under HTS 3004.31.00.00 as a mixed insulin product put up for retail therapeutic use.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Temperature-controlled shipping mandatory (2-8°C); include validated cold chain documentation to prevent FDA rejection
• Declare exact batch numbers and expiry dates; insulin imports require prior FDA Drug Establishment Registration